Journal list Promote Sponsor
Journal of Generic Medicines
United Kingdom · SAGE Publications Inc.
workspace_premium Q4 — Pharmaceutical Science lock Subscription

Journal of Generic Medicines

Journal of Generic Medicines is a journal indexed in SJR in Pharmaceutical Science with an H index of 14. It has a best quartile of Q4. It is published in English.

ISSN: 1741-1343
Publisher: SAGE Publications Inc.
Category: Pharmaceutical Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
NPD Q4
H-index 14
Acceptance rate pie_chart
45%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

14

Docs (year)

0

Docs 3y

30

Total refs

0

Cites 3y

5

Citable 3y

24

Cites/Doc 2y

21

Ref/Doc

0.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Book Review

View more

Would the Trans-Pacific Partnership Agreement undermine Japan's efforts to control health care expenditures?

View more

EU Case Reports

View more

Editorial

View more

Editorial

View more

Don't kill this goose: Government policy should facilitate India to become pharmacy of the world

View more

Does the patent office really believe delay occurs before it actually occurs? The effect of Wyeth et al v. Dudas on patent term adjustments

View more

Developing a legislative pathway for biosimilars in the United States

View more

Data protection: The new IP Frontier - An overview of existing laws and regulations

View more

Creating a workable biogenerics pathway for patients

View more

Carved out indications and patents in Australia: The story continues

View more

Branding of new and generic/biosimilar products: New concepts and methods (in-depth qualitative study)

View more
SHOW MORE ARTICLES

Book Reviews

View more

A buyer's guide to generic pharmaceutical acquisitions

View more

Biological generics: A business case

View more

Attention API suppliers: Quality agreements are here to stay

View more

Assessment of generic drug discount programs offered by large chain pharmacies in the United States

View more

Assessment methodology for performing regulatory due diligence based on a quantitative approach

View more

All costs, no benefits: How the US-Jordan free trade agreement affects access to medicines

View more

Abbott v. Sandoz: Judicial clarity on the interpretation of product-by-process claims

View more

Abbott v. Sandoz: If at first you don't succeed, try, try again

View more

A triumph for generic medicines and the right to health in Africa Patricia Asero Ochieng & Ors. v. Attorney General (Petition No. 409 of 2009, Judgment of the Kenyan High Court, 20 April 2012)

View more

A survey assessing knowledge and perception of prescribers towards generic medicines in Hospital Seberang Jaya

View more

A review of recent developments at the multilateral level with respect to intellectual property and the pharmaceutical industry

View more

FAQs